SPA
SANA icon

Sherbrooke Park Advisers’s Sana Biotechnology SANA Stock Holding History

Sherbrooke Park Advisers’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-48,339
Closed -$264K – 1219
2024
Q2 		$264K Buy
+48,339
New +$385K 0.05% 672
2024
Q1 		– Sell
-27,061
Closed -$110K – 981
2023
Q4 		$110K Buy
+27,061
New +$99.7K 0.05% 393
2023
Q3 		– Sell
-12,800
Closed -$76.3K – 608
2023
Q2 		$76.3K Buy
+12,800
New +$73.8K 0.04% 329

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Sherbrooke Park Advisers's SANA Position: Q3 2024 in Review

Sherbrooke Park Advisers sold out of Sana Biotechnology (SANA) in Q3 2024, closing a stake of 48,339 shares — an estimated $264K sold.

Sherbrooke Park Advisers first reported a position in SANA in Q2 2023 and held it in 3 quarters. The position peaked at $264K in Q2 2024. 155 funds tracked by Wall St. Rank hold SANA as of Q3 2024.

  • Sherbrooke Park Advisers reported no remaining Sana Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 48,339 Sana Biotechnology shares in Q3 2024, an estimated $264K.
  • Sherbrooke Park Advisers first reported a position in Sana Biotechnology in Q2 2023 and held it in 3 quarters.
  • Sherbrooke Park Advisers's Sana Biotechnology position peaked at $264K in Q2 2024.
  • 155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.